Skip to main content
Premium Trial:

Request an Annual Quote

ChromoCure, GRG Ink Cancer Treatment Monitoring Alliance

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – ChromoCure today said that it will collaborate with Genome Research Group in developing technologies for monitoring and determining the efficacy of cancer treatments.

Under the agreement, ChromoCure said that it will have access to GRG's therapeutic modeling protocols and algorithms that use hypothermic modulation and resonance for the non-toxic and non-invasive treatment of cancer. In return, GRG will have access to ChromoCure's chromosomal scanner technology, which includes a series of systems, processes, cell preparation techniques, and diagnostic algorithms.

ChromoCure's systems measure aneuploidy to detect cancer and measure cancer progression. The Reno, Nev.-based firm claims that its scanner is has a 100 percent accuracy rate.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.